4
Changes in Ownership
ArriVent BioPharma, Inc. Filed Acc 0001104659-26-010477
Options or other derivatives
- President of R&D acquired 150,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Lutzker Stuart President of R&D | 2026-02-02 | Grant or award · Stock Option (right to buy) | +150,000 | 150,000 | D | ||
Loading xslF345X05/tm265104-3_4seq1.xml…